ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 63 filers reported holding ONCOMED PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2016 | $83,000 | -68.6% | 10,800 | -53.2% | 0.00% | -100.0% |
| Q3 2016 | $264,000 | -10.5% | 23,100 | -3.8% | 0.00% | 0.0% |
| Q2 2016 | $295,000 | +173.1% | 24,000 | +124.3% | 0.00% | – |
| Q1 2016 | $108,000 | -75.9% | 10,700 | -46.2% | 0.00% | -100.0% |
| Q4 2015 | $448,000 | +35.8% | 19,900 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $330,000 | -26.2% | 19,900 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $447,000 | -37.4% | 19,900 | -28.2% | 0.00% | -33.3% |
| Q1 2015 | $714,000 | -2.3% | 27,700 | -17.6% | 0.00% | 0.0% |
| Q4 2014 | $731,000 | -38.4% | 33,600 | -46.4% | 0.00% | 0.0% |
| Q3 2014 | $1,186,000 | +1175.3% | 62,694 | +1467.4% | 0.00% | – |
| Q2 2014 | $93,000 | – | 4,000 | – | 0.00% | – |
| Q1 2014 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2013 | $56,000 | +75.0% | 1,900 | -9.5% | 0.00% | – |
| Q3 2013 | $32,000 | – | 2,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 825,647 | $19,238,000 | 3.04% |
| SECTORAL ASSET MANAGEMENT INC | 1,392,485 | $32,445,000 | 1.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 75,000 | $1,748,000 | 0.43% |
| Eventide Asset Management | 52,800 | $1,230,000 | 0.17% |
| Alyeska Investment Group, L.P. | 250,434 | $5,835,000 | 0.13% |
| Convergence Investment Partners, LLC | 28,715 | $669,000 | 0.09% |
| COLUMBUS CIRCLE INVESTORS | 253,348 | $5,903,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 66,800 | $1,557,000 | 0.04% |
| Visium Asset Management, LP | 75,001 | $1,748,000 | 0.03% |
| Hodges Capital Management Inc. | 15,000 | $349,000 | 0.02% |